Related Experiment Videos
GEP31, a new gastric epithelial protein, early expressed during ontogenesis
B Lupo1, G Devilliers, F Mercier
1Centre CNRS-INSERM de Pharmacologie-Endocrinologie, Montpellier/France.
Insights
Researchers identified GEP31, a novel gastric epithelial antigen, as the earliest specific cell surface marker during gastric mucosa development. This discovery offers new insights into gastrointestinal epithelial development.
Area of Science:
- Gastroenterology
- Developmental Biology
- Molecular Biology
Background:
- Gastric mucosa development involves complex cellular differentiation.
- Specific cell surface markers are crucial for understanding tissue development.
- Previous studies identified markers like proton pump and mucins.
Purpose of the Study:
- To characterize GEP31, a novel 31 kDa cell surface antigen.
- To investigate the developmental expression of GEP31 in gastric mucosa.
- To compare GEP31 expression with other gastric differentiation markers.
Main Methods:
- Production and characterization of monoclonal antibodies (mabs).
- Immunohistochemical analysis of gastric mucosa during ontogenesis.
- Partial N-terminal amino acid sequencing of GEP31.
Main Results:
- Monoclonal antibody mab 81.1 identified GEP31, a 31 kDa protein in the gastrointestinal tract.
- GEP31 was detected at day 18 of gastric mucosa development, preceding other markers.
- GEP31 expression increased between days 18 and 19.
- GEP31 is a novel protein with no known N-terminal sequence homology.
Conclusions:
- GEP31 is the earliest identified specific cell surface epithelial gastric antigen.
- GEP31 serves as a potential early marker for gastric epithelial development.
- The novel nature of GEP31 opens avenues for further research into gastric biology.
Abstract:
A set of monoclonal antibodies directed against various gastric markers was produced in order to study the developmental expression of the gastric mucosa. A previously described monoclonal antibody, mab 146.14, labeled the proton pump (H+, K+) ATPase specifically located in gastric parietal cells. Mabs 15.1 and 121.17 revealed the mucus of mucous neck cells and mucous surface cells, respectively. By addition, mab 81.1 was directed against a cell surface membrane protein antigen composed of a major 31 kDa component (called GEP31). Our study mainly focused on the characterization of GEP31. This protein was typically located in the gastrointestinal epithelial tract (stomach, small intestine, colon). Moreover, interesting features were observed during the study of the early ontogenesis of the gastric mucosa. The 31 kDa protein was detected at the onset of gland formation (day 18), and a gradual increase in expression of the protein could be observed between day 18 and day 19. Furthermore, a comparative study of the expression of different terminal differentiation markers of gastric epithelial cells ((H+, K+) ATPase, mucins) during the early period of ontogenesis revealed that GEP31 could be detected well before the appearance of these markers. To our knowledge, GEP31 thus appears as the earliest expressed specific cell surface epithelial gastric antigen described to date. Furthermore, the partial N-terminal amino acid sequence of GEP31 was determined and revealed that it is not a known protein.